ACTAVIA LIFE SCIENCES, INC.
company.status.inactiveCIK 1582249fmd_07NE00AFN6BTSHYTQ3JPD8AX4FManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2012 to Mar 31, 2024, 44 periods
| Line item | FY2015 | FY2016 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | – | 0 | 0 | – | – | – | – | – |
| Cost of revenue | – | 0 | – | 0 | 0 | – | – | – | – | – |
| Gross profit | – | 0 | – | 0 | 0 | – | – | – | – | – |
| Research and development | – | 0 | – | 2 | 0 | 0 | – | 0 | 0 | 0 |
| Net interest income after provision | – | – | – | – | – | – | (5) | (1) | – | – |
| Total operating expenses | 0 | – | 0 | – | 4 | 1 | 5 | 0 | (0) | 4 |
| Operating income | (0) | – | (0) | – | (4) | (1) | (5) | (0) | 0 | (4) |
| Interest expense | – | – | – | – | 0 | 0 | 0 | – | 0 | 0 |
| Other non-operating income (expense) | – | 0 | – | 0 | (0) | (0) | 0 | (1) | (1) | (0) |
| Income before taxes | (0) | – | – | (4) | (4) | (1) | (5) | (0) | – | – |
| Income tax expense | 0 | – | 0 | – | 0 | (0) | (0) | – | – | – |
| Net income from continuing operations | (0) | – | – | – | (4) | (1) | (5) | – | – | – |
| Net income | (0) | – | (0) | – | (4) | (1) | (5) | (1) | (1) | (4) |